Xiamen Innodx Biotech Co., Ltd.

(a) pre-market release review of products placed on the EU market; (b) ensure the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date; (c) ensure the relevant post-market surveillance obligations are complied with; (d) ensure the relevant reporting obligations are fulfilled; (e) for devices used in clinical performance studies, ensure the company signs a relevant declaration.